通过与抗瘤免疫治疗的低pH插入化物融合IL-2的瘤向输送
Tianjiao Chu1,2, Bowei Cao2, Peina Wang2,3
1College of Pharmaceutical Science, Jilin University, Changchun 130021, China.
Bioconjugate chemistry
|October 3, 2023
概括
一种新型的融合蛋白,pHLIP-IL2,向酸性瘤,增强癌症回归的杀手免疫细胞. 这种方法改善了干白素-2 (IL-2) 疗法,降低了毒性,并在临床前模型中提高了疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 介素-2 (IL-2) 是一种强大的抗瘤免疫细胞因子,但由于半衰期短和毒性高,它面临着局限性.
- 目前对癌症患者的IL-2的应用受到限制,这阻碍了其广泛的临床使用.
研究的目的:
- 通过将低pH插入 (pHLIP) 与IL-2融合,开发一种新的瘤向剂.
- 在酸性瘤微环境中增强IL-2的输送和有效性.
- 在临床前癌症模型中评估pHLIP-IL2融合蛋白的治疗潜力.
主要方法:
- 构建一个融合蛋白 (pHLIP-IL2),将pHLIP的低pH插入能力与IL-2的免疫刺激特性结合起来.
- 将pHLIP-IL2用于各种瘤模型,包括乳腺癌和黑色素瘤.
- 评估pHLIP-IL2丰富的瘤组织,免疫细胞的增殖,瘤大小的减少,和不良影响.
主要成果:
- pHLIP-IL2融合蛋白在酸性瘤组织中显示有选择性的积累.
- 融合蛋白有效地促进了杀手免疫细胞的增殖.
- 在乳腺癌和黑色素瘤模型中观察到显著的瘤大小减少.
- 与传统的IL-2疗法相比,pHLIP-IL2的副作用减少.
结论:
- 聚合蛋白pHLIP-IL2代表了针对癌症免疫治疗的有希望的策略.
- 这种新型药物克服了传统IL-2的局限性,为更广泛的临床应用提供了潜力.
- pHLIP-IL2显示出作为癌症患者有价值的治疗药物的潜力,增强抗瘤免疫疗法.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.4K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
相关概念视频
01:27Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K